ArticleDiscover oncology2024

AI-powered genomic mutation signature for predicting immune checkpoint inhibitor therapy outcomes in gastroesophageal cancer: a multi-cohort analysis.

Bingyin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.